 |
Most studied contents |
 |
Editorial Board ( 40832 view) |
|
About Journal ( 27493 view) |
|
Indexing &Abstracting ( 19732 view) |
|
Submission Instruction ( 18408 view) |
|
Contact Information ( 16213 view) |
|
Aims and Scope ( 15630 view) |
|
Call for Papers ( 15382 view) |
|
Open Access Policy ( 13603 view) |
|
Is COVID-19 Risk Linked to Blood Type? ( 13171 view) |
|
Reviewers List ( 12182 view) |
|
Call for paper for special issue on Nanoscience and Nanotechnology ( 12140 view) |
|
Peer Review policy ( 11013 view) |
|
CrossMark Policy ( 10734 view) |
|
Ethical Principles for Psychological Research ( 10525 view) |
|
Publishing Ethics ( 9611 view) |
|
Editorial policies ( 8759 view) |
|
Policies of Peer Review ( 8727 view) |
|
Registration Information ( 7317 view) |
|
Ethical Principles for Medical Research ( 6870 view) |
|
Conflicts of Interest ( 6790 view) |
|
Compatibility of Commonly Used IV Drugs ( 6270 view) |
|
Social isolation can lead to depression in children long after current lockdown ( 5823 view) |
|
International Conference on Cell Science and Molecular Biology December 02-04, 2021 Rome, Italy ( 5811 view) |
|
FDA Approves Vegzelma, a Biosimilar to Bevacizumab, for Six Types of CancerFDA Approves Vegzelma, a Biosimilar to Bevacizumab, for Six Types of Cancer ( 5770 view) |
|
COVID-19 resources: serological tests, face masks and benefits of physical activity ( 5502 view) |
|
Webinars for the Week of July 6th ( 5434 view) |
|
What do we know for sure about hydroxychloroquine for COVID-19? Not much ( 5277 view) |
|
Introduction to testing for COVID-19 ( 5243 view) |
|
Upcoming Events of the ACSE ( 5080 view) |
|
Korean Biopharmaceutical Firm Celltrion Launches Both Antigen and Antibody Testing Kits in the US ( 5059 view) |
|
From Brain to Behavior: The Search for Biomarkers ( 5044 view) |
|
Poor cardiovascular health may contribute to the development of musculoskeletal disorders ( 4928 view) |
|
Share your COVID experiences with 2 million+ researchers ( 4847 view) |
|
Happy Peer Review Week from ACS Publications ( 4821 view) |
|
COVID-19 Anticoagulation Trials 'Paused' for Futility, Safety ( 4615 view) |
|
COVID-19: Bacteriophage Could Decrease Mortality ( 4583 view) |
|
Animal Models of COVID-19 ( 4490 view) |
|
FDA approves generic albuterol inhaler to mitigate shortages during pandemic ( 4483 view) |
|
Study Finds No Significant Effect on Infusion Reactions, Cardiac Dysfunction When Switching from Trastuzumab to Biosimilar in HER2-Positive Breast Cancer ( 4442 view) |
|
Cancer deaths set to decline new analysis suggests ( 4368 view) |
|
Immunotherapies, PARP Inhibitors Show Promise in Early Stage, Triple-Negative Breast Cancers ( 4218 view) |
|
Presymptomatic Atherosclerosis May Contribute to the Development of Alzheimer Disease Later in Life ( 4107 view) |
|
MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer ( 4092 view) |
|
Hologic Showcased Latest Advances at Virtual ECR Congress 2020 ( 4084 view) |
|
Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkers ( 4076 view) |
|
Pharmacy chain appeals to older people and vulnerable to get latest Covid-19 booster ( 3945 view) |
|
Female Patients Hospitalized With COVID-19 Are Less Likely to Have Cardiovascular Complications ( 3867 view) |
|
Statin alternative joins drugs that could reduce heart attack risk ( 3855 view) |
|
WHO says global childhood vaccinations closer to prepandemic levels ( 3788 view) |
|
Anticoagulants Can Ease Cognitive Decline in AF Patients ( 3655 view) |
